Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells

作者: Ruiguang Hou , Cang Liu , Jing Zhang

DOI: 10.3978/J.ISSN.1000-9604.2014.12.05

关键词:

摘要: Background: The purposes of this study were to explore the effects high mobility group protein box 1 (HMGB1) gene on growth, proliferation, apoptosis, invasion, and metastasis glioma cells, with an attempt provide potential therapeutic targets for treatment glioma. Methods: expressions HMGB1 in cells (U251, U-87MG LN-18) one control cell line (SVG p12) detected by real time PCR Western blotting, respectively. Then, biological behaviors detected: expression human lines U251 suppressed using RNAi technique, then influences viability, cycle, invasion abilities analyzed a Transwell chamber. Also, cyclin D1, Bax, Bcl-2, MMP 9 detected. Results: As shown real-time significantly increased U-87MG, comparison p12); vitality, proliferation invasive capabilities siRNA-transfected lower than those blank negative (NC) siRNA (P<0.05) but showed no significant difference between NC group. percentage apoptotic was higher similar latter two groups. had levels Cyclin MMP- Bax (P<0.05); profiles change both Conclusions: may promote migration suppress its apoptosis. Inhibition can their Our observations provided new target intervention

参考文章(56)
Swadesh K Das, Sujit K Bhutia, Timothy P Kegelman, Leyla Peachy, Regina A Oyesanya, Santanu Dasgupta, Upneet K Sokhi, Belal Azab, Rupesh Dash, Bridget A Quinn, Keetae Kim, Paola M Barral, ZZ Su, Habib Boukerche, Devanand Sarkar, Paul B Fisher, MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Frontiers in Bioscience. ,vol. 17, pp. 1- 15 ,(2012) , 10.2741/3911
Chun Li, Junjie Li, Sanjay Gupta, Research perspectives: gold nanoparticles in cancer theranostics. Quantitative imaging in medicine and surgery. ,vol. 3, pp. 284- 291 ,(2013) , 10.3978/J.ISSN.2223-4292.2013.12.02
Michael K. Cooper, Yufang Ma, Jialiang Wang, Cancer stem cells in glioma: challenges and opportunities. Translational cancer research. ,vol. 2, pp. 429- 441 ,(2013) , 10.3978/J.ISSN.2218-676X.2013.08.01
Anjana Ranganathan, David Casarett, Orvar Gunnarsson, Palliative care and advance care planning for patients with advanced malignancies Annals of palliative medicine. ,vol. 3, pp. 144- 149 ,(2014) , 10.3978/J.ISSN.2224-5820.2014.07.04
JING ZHANG, YU-BIN KOU, JIN-SHUI ZHU, WEI-XIONG CHEN, SHUANG LI, Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo International Journal of Oncology. ,vol. 44, pp. 1268- 1276 ,(2014) , 10.3892/IJO.2014.2285
Jean O Thomas, Andrew A Travers, HMG1 and 2, and related ‘architectural’ DNA-binding proteins Trends in Biochemical Sciences. ,vol. 26, pp. 167- 174 ,(2001) , 10.1016/S0968-0004(01)01801-1
Daolin Tang, Rui Kang, Herbert J. Zeh III, Michael T. Lotze, High-mobility group box 1 and cancer Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. ,vol. 1799, pp. 131- 140 ,(2010) , 10.1016/J.BBAGRM.2009.11.014
Michael Bustin, Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends in Biochemical Sciences. ,vol. 26, pp. 152- 153 ,(2001) , 10.1016/S0968-0004(00)01777-1
D. Baskaran, P. V. Spirin, V. S. Prassolov, Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells Molecular Biology. ,vol. 44, pp. 369- 379 ,(2010) , 10.1134/S0026893310030039